Blocking LINGO-1 in vivo reduces degeneration and enhances regeneration of the optic nerve
{{output}}
Background: Two ongoing phase II clinical trials (RENEW and SYNERGY) have been developed to test the efficacy of anti-LINGO-1 antibodies in acute optic neuritis and relapsing forms of multiple sclerosis, respectively. Across a ra... ...
